Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,165 | -976 | -713 | -558 | -344 |
| Depreciation Amortization | 54 | 13 | 34 | 21 | 9 |
| Accounts payable and accrued liabilities | 119 | N/A | N/A | 303 | -187 |
| Other Working Capital | 459 | -79 | 64 | 336 | -161 |
| Other Operating Activity | 640 | 925 | 374 | -303 | 483 |
| Operating Cash Flow | $-893 | $-118 | $-241 | $-201 | $-201 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | 183 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $183 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 709 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | 32 | N/A | N/A | N/A |
| Common Stock Issued | 83 | 83 | 240 | 200 | 200 |
| Financing Cash Flow | $792 | $115 | $240 | $200 | $200 |
| Beginning Cash Position | 3 | 4 | 4 | 4 | 4 |
| End Cash Position | 84 | 1 | 3 | 3 | 3 |
| Net Cash Flow | $82 | $-3 | $-1 | $-1 | $-1 |
| Free Cash Flow | |||||
| Operating Cash Flow | -893 | -118 | -241 | -201 | -201 |
| Free Cash Flow | -893 | -118 | -241 | -201 | -201 |